4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-025792
Options or other derivatives
- Director acquired 14,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Young Matthew P. Director | 2017-06-20 | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | D: show line 1 in the form |
Loading xslF345X03/doc1.xml…